DR. CHARLES H. HALSTED, M.D.
Medical Practice at J St, Sacramento, CA
License number
California 207REO10X
Category
Medical Practice
Type
Specialist
Address
Address
2
2825 J St SUITE 300, Sacramento, CA 95816
451 Gbsf, Davis, CA 95616
451 Gbsf, Davis, CA 95616
Phone
(916) 734-2890
(530) 752-6778
(530) 752-6778
Personal information
See more information about CHARLES H. HALSTED at radaris.comName
Address
Phone
506 Jerome St, Davis, CA 95616
506 Jerome St, Davis, CA 95616
16 Parkside Dr, Davis, CA 95616
Organization information
See more information about CHARLES H. HALSTED at bizstanding.comCharles H Halsted MD
451 E Health Sciences Dr, Davis, CA 95616
Categories:
Physicians & Surgeons
Phone:
(530) 752-4054 (Phone)
Charles H Halsted MD
2825 J St, Sacramento, CA 95816
Industry:
Medical Doctor's Office
Medical Doctor:
Charles Halsted (Medical Doctor)
Professional information
Charles H Halsted, Sacramento CA
Specialties:
Internist
Address:
2825 J St, Sacramento, CA 95816
Education:
University of Rochester, School of Medicine and Dentistry - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)
Charles Hopkinson Halsted, Sacramento CA
Specialties:
Internal Medicine, Gastroenterology, Endocrinology, Diabetes & Metabolism, Endocrinology and Metabolism
Work:
Uc Davis Medical Ctr
2825 J St, Sacramento, CA 95816 Ucdmc, Lawrence J. Ellison Ambulatory Care Center
4860 Y St, Sacramento, CA 95817
2825 J St, Sacramento, CA 95816 Ucdmc, Lawrence J. Ellison Ambulatory Care Center
4860 Y St, Sacramento, CA 95817
Education:
University of Rochester(1962)
Dr. Charles H Halsted, Sacramento CA - MD (Doctor of Medicine)
Address:
2825 J St SUITE 400, Sacramento 95816
(916) 734-0779 (Phone), (916) 734-0804 (Fax)
UNIVERSITY OF CALIFORNIA DAVIS MEDICAL GROUP
2825 J St SUITE 300, Sacramento 95816
(916) 734-7777 (Phone), (916) 734-8059 (Fax)
(916) 734-0779 (Phone), (916) 734-0804 (Fax)
UNIVERSITY OF CALIFORNIA DAVIS MEDICAL GROUP
2825 J St SUITE 300, Sacramento 95816
(916) 734-7777 (Phone), (916) 734-8059 (Fax)
Hospitals:
2825 J St SUITE 400, Sacramento 95816
UNIVERSITY OF CALIFORNIA DAVIS MEDICAL GROUP
2825 J St SUITE 300, Sacramento 95816
Sutter General Hospital
5151 F St, Sacramento 95819
UC Davis Medical Center
2315 Stockton Blvd, Sacramento 95817
UNIVERSITY OF CALIFORNIA DAVIS MEDICAL GROUP
2825 J St SUITE 300, Sacramento 95816
Sutter General Hospital
5151 F St, Sacramento 95819
UC Davis Medical Center
2315 Stockton Blvd, Sacramento 95817
Education:
Medical Schools
University of Rochester
Graduated: 1962
University of Rochester
Graduated: 1962
Mutations In Human Glutamate Carboxypeptidase Ii Gene Impacting Folate Metabolism, And Detection Of Affected Individuals
US Patent:
2004018, Sep 23, 2004
Filed:
Mar 3, 2004
Appl. No.:
10/794282
Inventors:
Charles Halsted - Davis CA, US
Angela Devlin - Walnut Creek CA, US
Angela Devlin - Walnut Creek CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
C12Q001/00, C12Q001/68
US Classification:
435/006000
Abstract:
The invention provides methods for detecting mutations in the human GCPII gene which affect the ability of an individual to hydrolyze terminal glutamates from dietary folates. Such individuals are at increased risk for conditions associated with hyperhomocyteinemia, in particular, cardiovascular disease, colon cancer, and altered cognition in the elderly, including Alzheimer's disease. In addition, pregnant women with low folate status are at increased risk of bearing children with neural tube defects and congenital heart defects. Individuals with these mutations can be screened and treated with supplementation of their diet with folic acid.
Mutations In Human Glutamate Carboxypeptidase Ii Gene Impacting Folate Metabolism, And Detection Of Affected Individuals
US Patent:
2002000, Jan 24, 2002
Filed:
Mar 12, 2001
Appl. No.:
09/805293
Inventors:
Charles Halsted - Davis CA, US
Angela Devlin - Walnut Creek CA, US
Angela Devlin - Walnut Creek CA, US
International Classification:
C12Q001/68, C12P019/34
US Classification:
435/006000, 435/091200
Abstract:
The invention provides methods for detecting mutations in the human GCPII gene which affect the ability of an individual to hydrolyze terminal glutamates from dietary folates. Such individuals are at increased risk for conditions associated with hyperhomocyteinemia, in particular, cardiovascular disease, colon cancer, and altered cognition in the elderly, including Alzheimer's disease. In addition, pregnant women with low folate status are at increased risk of bearing children with neural tube defects and congenital heart defects. Individuals with these mutations can be screened and treated with supplementation of their diet with folic acid.